Retatrutide is a lyophilized powder research compound acting as a triple agonist on GIP, GLP-1, and glucagon receptors. Our current lot, AM20260925-01, tested 99.724% HPLC purity with identity confirmed by Accumark Labs (report CW6X-76R7, completed Sep 28, 2026)
Lot AM20260925-01
Tested on the 10.467 mg vial
Sample received Sep 24, 2026 · Analysis completed Sep 28, 2026
Conforms spec > 98.0%
Conforms
Measured
Figures copied exactly from Accumark Labs's report CW6X-76R7.
Catalog no. PH-RETA-001Size 10mgMW (reference) 4,731 DaMechanism GIP/GLP-1/Glucagon triple agonist
Retatrutide is a lyophilized powder research compound acting as a triple agonist on GIP, GLP-1, and glucagon receptors. It has a purity of 99.724% and a molecular weight of 4,731 Da. This compound is intended for metabolic receptor pharmacology research. Store at -20°C protected from light. For laboratory research use only.
Mechanism of Action
Retatrutide (LY3437943) is a unimolecular triple agonist at GIP, GLP-1, and glucagon receptors. Phase 2 RCT (n=338): -17.5% mean body-weight change at 24 weeks (12 mg group) vs -1.6% placebo; -24.2% at 48 weeks vs -2.1% placebo (Jastreboff et al., 2023).
Research Applications
References
Retatrutide is supplied as a lyophilized powder. Keep it sealed, dry, and away from light until reconstitution.
Lyophilized material is stable when frozen. Once reconstituted, keep it cold and minimise handling to preserve integrity.
Retatrutide is a synthetic peptide compound used in laboratory research settings. Researchers studying metabolic regulation and energy homeostasis use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Its available Certificate of Analysis documents the reported laboratory results.
Retatrutide is a research compound supplied for in-vitro laboratory use. Also known as Reta. Mechanism class: GIP/GLP-1/Glucagon triple agonist. Supplied for metabolic research laboratory research. A third-party Certificate of Analysis is published for the current lot. Research Use Only — not for human or veterinary use.
The current Certificate of Analysis for Retatrutide reports 99.724% purity by HPLC (Accumark Labs report CW6X-76R7).
Yes. Accumark Labs report CW6X-76R7 for Retatrutide is on our COA page, with a link to the lab's own report.
Retatrutide is supplied as a lyophilized powder. Store it at −20°C or below, protected from light and moisture — lyophilized material is stable frozen. Once reconstituted, keep it refrigerated and avoid freeze-thaw cycles.
Orders ship at a $15 flat rate, free on orders of $200 or more, in discreet, insulated packaging. Domestic delivery takes 2–3 business days — 2-day across California, nearby Nevada, and on orders of $250+.
No. Retatrutide is supplied strictly for in-vitro laboratory research. It is not for human or veterinary use, consumption, or diagnostic or clinical applications.
Yes. Retatrutide is also spelled or referred to as Reta. These are naming variants of the same compound, not different products.
Retatrutide's CAS Registry Number is 2381089-83-2, per PubChem (CID 171390338).
Open the lab report link on our certificate page — it goes to Accumark Labs's own verification portal, not a file we host, so the result can't be edited by us. Confirm the report ID (CW6X-76R7) and figures match what's shown here.
The 10mg size of Retatrutide is $9.50 per mg. See the size selector above for per-mg pricing on every available size.
